MLIM
UTHR icon

Mountain Lake Investment Management’s United Therapeutics UTHR Stock Holding History

Mountain Lake Investment Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-18,000
Closed -$2.04M – 23
2018
Q2 		$2.04M Sell
18,000
-2,600
-13% -$286K 1.03% 18
2018
Q1 		$2.31M Buy
+20,600
New +$2.62M 1.2% 16

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Mountain Lake Investment Management's UTHR Position: Q3 2018 in Review

Mountain Lake Investment Management sold out of United Therapeutics (UTHR) in Q3 2018, closing a stake of 18,000 shares — an estimated $2.04M sold.

Mountain Lake Investment Management first reported a position in UTHR in Q1 2018 and held it in 2 quarters. The position peaked at $2.31M in Q1 2018. 367 funds tracked by Wall St. Rank hold UTHR as of Q3 2018.

  • Mountain Lake Investment Management reported no remaining United Therapeutics position as of Q3 2018 after selling out during the quarter.
  • Mountain Lake Investment Management sold 18,000 United Therapeutics shares in Q3 2018, an estimated $2.04M.
  • Mountain Lake Investment Management first reported a position in United Therapeutics in Q1 2018 and held it in 2 quarters.
  • Mountain Lake Investment Management's United Therapeutics position peaked at $2.31M in Q1 2018.
  • 367 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2018.

Based on Mountain Lake Investment Management's 13F filing for Q3 2018, filed 14 Nov 2018.